Pharmaceuticals, Biotechnology and Life Sciences
BOSTON, Nov. 04, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (NASDAQ: APRE), a biopharmaceutical company focused on developing and commercializing…
Successfully completed multiple ascending dose (MAD) portion of a Phase 1 clinical trial for LP352, a potential treatment for seizures…
CAMBRIDGE, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the…
Company to host an investor conference call and webcast at 5:00pm ET on that dayNEW YORK, Nov. 04, 2021 (GLOBE…
– Entered into additional licensing agreement with The University of Texas MD Anderson Cancer Center for use of CaspaCIDe® safety…
Leading global genomics and diagnostic testing firm adds more comprehensive genetic information to its services.MENLO PARK, Calif. and HONG KONG,…
LA JOLLA, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…
AUSTIN, TX and DURHAM, NC, Nov. 03, 2021 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology…
SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the…
SUNNYVALE, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research…